Display options
Share it on

Ann Cardiothorac Surg. 2014 Sep;3(5):490-5. doi: 10.3978/j.issn.2225-319X.2014.09.01.

Evaluation and treatment of pump thrombosis and hemolysis.

Annals of cardiothoracic surgery

Vakhtang Tchantchaleishvili, Fabio Sagebin, Ronald E Ross, William Hallinan, Karl Q Schwarz, H Todd Massey

Affiliations

  1. 1 Division of Cardiothoracic Surgery, 2 Department of Cardiology, University of Rochester Medical Center, Rochester, NY 14642, USA.

PMID: 25452909 PMCID: PMC4229473 DOI: 10.3978/j.issn.2225-319X.2014.09.01

Abstract

Ventricular assist devices (VADs) are not fully biocompatible, and are therefore predisposed to device thrombosis and subsequent pump dysfunction. Clinically significant hemolysis in VADs most often occurs as a result of device thrombosis, but can also be caused by other factors. Herein we describe the evaluation and management of VAD thrombosis and hemolysis.

Keywords: Ventricular assist device (VAD); hemolysis; thrombosis

References

  1. Ann Thorac Surg. 1996 Nov;62(5):1321-7; discussion 1328 - PubMed
  2. N Engl J Med. 2014 Jan 2;370(1):33-40 - PubMed
  3. ASAIO J. 2011 Jan-Feb;57(1):32-7 - PubMed
  4. ASAIO J. 2013 Nov-Dec;59(6):671-4 - PubMed
  5. J Heart Lung Transplant. 2012 Jul;31(7):715-8 - PubMed
  6. J Heart Lung Transplant. 2010 Jun;29(6):616-24 - PubMed
  7. J Heart Lung Transplant. 2014 Jan;33(1):12-22 - PubMed
  8. JACC Cardiovasc Imaging. 2013 Nov;6(11):1129-40 - PubMed
  9. J Am Coll Cardiol. 2012 Oct 30;60(18):1764-75 - PubMed
  10. J Heart Lung Transplant. 2014 Jan;33(1):51-9 - PubMed

Publication Types